An incidence-based model was developed to estimate the annual ischemic and hemorrhagic stroke–related healthcare costs to a hypothetical US health plan with 1 million enrollees.
Iris Lin, PhD
Advertisement
Articles by Iris Lin, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves XFG-Adapted COVID-19 Vaccine, mRNA for the 2026-2027 Season
2
Building the pharmacy of the future — trust, loyalty, and growth
3
Beyond the Transplant Center: IV Therapy in the Community
4
Incorporating Patient-Reported Symptoms into Treatment Plans
5